Welcome to our dedicated page for Park Dental SEC filings (Ticker: PARK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page is intended to present U.S. Securities and Exchange Commission (SEC) filings for Park Dental Partners, Inc. (NASDAQ: PARK), a dental resource organization that supports affiliated general and multi-specialty dental practices. Although no specific filings are listed in the available data here, as a Nasdaq-listed company Park Dental Partners files registration statements and other reports with the SEC in connection with its securities offerings and public company status.
In connection with its initial public offering of common stock, the company filed a registration statement that was declared effective by the SEC. The offering was conducted using a prospectus forming part of that registration statement. Investors and researchers typically look to such filings, along with annual and quarterly reports when available, to understand a company’s business model, risk factors, and capital structure.
On this SEC filings page for PARK, Stock Titan’s platform is designed to surface key regulatory documents as they become available from the SEC’s EDGAR system. These may include registration statements related to offerings, as well as periodic and current reports that describe Park Dental Partners’ operations as a dental resource organization, its relationships with affiliated practices, and other required disclosures.
AI-powered tools on the platform can help interpret lengthy filings by highlighting important sections and summarizing complex language into more accessible explanations. Users can use these features to quickly identify information related to Park Dental Partners’ business support services, its network of affiliated practices, and details connected to its public offering and any subsequent filings.
SMITH PHILIP IRVING reported acquisition or exercise transactions in this Form 4 filing.
Park Dental Partners, Inc. director Philip Irving Smith received a grant of 2,632 restricted stock units as equity compensation. Each unit represents one share of common stock and was granted for no cash consideration. The units vest in full on the first anniversary of the grant date, contingent on his continued board service, giving him 2,632 RSUs outstanding after this award.
SWENSON PETER G reported acquisition or exercise transactions in this Form 4 filing.
Park Dental Partners, Inc. CEO and Chairman Peter G. Swenson received a grant of 23,785 restricted stock units as equity compensation. Each unit represents a right to receive one share of common stock upon vesting and was granted for no cash consideration.
The restricted stock units vest in four equal installments of 25% on each of the first four anniversaries of the grant date, contingent on Swenson’s continued service and the terms of the award agreement. Following this grant, he holds 23,785 restricted stock units directly.
Steele Christopher Eugene reported acquisition or exercise transactions in this Form 4 filing.
Park Dental Partners, Inc. reported that director and officer Christopher Eugene Steele received a grant of 5,855 restricted stock units. Each unit represents the right to receive one share of common stock if and when it vests.
The award vests in four equal installments of 25% on each of the first four anniversaries of the grant date, so long as Steele continues to provide service and satisfies the award terms. The units were granted for no cash consideration, reflecting routine equity-based compensation rather than an open-market share purchase or sale.
Smith Christopher Charles reported acquisition or exercise transactions in this Form 4 filing.
Park Dental Partners, Inc. reported that director Christopher Charles Smith received a grant of 2,632 restricted stock units. Each unit represents one share of common stock, granted for no cash consideration. The award vests in full on the first anniversary of the grant date, contingent on his continued board service.
Bernander Christopher James reported acquisition or exercise transactions in this Form 4 filing.
Park Dental Partners, Inc. reported that Chief Financial Officer Christopher James Bernander received a grant of 11,184 restricted stock units. Each unit represents a contingent right to receive one share of Park Dental Partners common stock upon vesting.
The restricted stock units vest in four equal 25% installments on each of the first four anniversaries of the grant date, conditioned on his continued service and the terms of the award agreement. The units were granted for no cash consideration, and following this award Bernander holds 11,184 restricted stock units directly.
Schaefer Anna Marie reported acquisition or exercise transactions in this Form 4 filing.
Park Dental Partners, Inc. reported that director Anna Marie Schaefer received a grant of 2,632 restricted stock units (RSUs). Each RSU represents one share of common stock upon vesting. The RSUs vest in full on the first anniversary of the grant date, and were granted for no cash consideration.
Law Alan Siems reported acquisition or exercise transactions in this Form 4 filing.
Park Dental Partners, Inc. reported that director and officer Alan Siems received a grant of 7,796 restricted stock units. Each unit represents a contingent right to receive one share of common stock upon vesting. The award was granted for no cash consideration.
The restricted stock units vest in four equal installments of 25% on each of the first four anniversaries of the grant date, conditioned on Mr. Siems’ continued service and the terms of the applicable award agreement. Following this grant, he holds 7,796 restricted stock units directly.
Park Dental Partners, Inc. disclosure amends a beneficial ownership statement showing Nicholas John Swenson (via related entities AO Partners I, Park Investors LLC and AO Partners LLC) beneficially owns 295,208 shares of Common Stock, representing 6.36% of the class. The filing lists shared voting and dispositive power across the entities: 125,977, 169,231, and 125,977 shares respectively. Signatures show Mr. Swenson signed on behalf of the named entities.
Park Dental Partners, Inc. reported voting results from its 2026 annual shareholder meeting. Shareholders elected Christopher C. Smith as a Class II director to serve until the 2029 annual meeting, with 4,214,835 votes for, 586,587 withheld, and 478,173 broker non-votes.
Shareholders also ratified Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, with 5,145,444 votes for, 1,047 against, 133,104 abstentions, and no broker non-votes. A quorum was present, with 5,279,595 of 6,608,919 eligible shares represented.
Park Dental Partners reported Q1 2026 results showing higher revenue but lower profitability. Revenue rose 6.2% to $62.7 million, driven by increased patient visits, higher reimbursement rates, and contributions from acquisitions. However, gross margin fell as salaries and benefits jumped, including $4.0 million of share-based compensation, leading to an operating loss of $1.9 million and a net loss of $0.4 million, versus a prior-year profit. Adjusted EBITDA declined 13.2% to $4.7 million, while cash flow from operations remained solid at $5.0 million. The company ended the quarter with $24.4 million in cash, $11.5 million of debt, 221 dentists across 86 locations, and significant deferred compensation obligations.